These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34143177)

  • 1. Melatonin against pulmonary arterial hypertension: is it ready for testing in patients?
    Maarman GJ; Lecour S
    Cardiovasc J Afr; 2021; 32(2):111-112. PubMed ID: 34143177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy Improved Pulmonary Arterial Hypertension in a Patient with Chronic-Active Epstein-Barr Virus Infection.
    Akagi S; Miki T; Sando Y; Fujii N; Sarashina T; Nakamura K; Ito H
    Int Heart J; 2020 Jan; 61(1):191-194. PubMed ID: 31956153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An easy method for monitoring patients with pulmonary Hypertension: P-wave dispersion.
    Cimen AO; Emet S
    Cardiovasc J Afr; 2020; 31(4):75-80. PubMed ID: 31544202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
    Mulvaney EP; Reid HM; Bialesova L; Bouchard A; Salvail D; Kinsella BT
    BMC Pulm Med; 2020 Apr; 20(1):85. PubMed ID: 32252727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular-vascular coupling ratio in pediatric pulmonary arterial hypertension: A comparison between cardiac magnetic resonance and right heart catheterization measurements.
    Breeman KTN; Dufva M; Ploegstra MJ; Kheyfets V; Willems TP; Wigger J; Hunter KS; Ivy DD; Berger RMF; Truong U
    Int J Cardiol; 2019 Oct; 293():211-217. PubMed ID: 31109778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of F-ASO and Targeted Medical Therapy in Patients With Secundum ASD and Severe PAH.
    Yan C; Pan X; Wan L; Li H; Li S; Song H; Liu Q; Zhang F; Liu Y; Jiang Y; Wang L; Fang W
    JACC Cardiovasc Interv; 2020 Sep; 13(17):2024-2034. PubMed ID: 32800498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrecognized pulmonary arterial hypertension in hospitalized patients.
    Carpio AM; Goertz A; Kelly C; Willes L; Quan SF; Pressman GS; Niroula A; Sharma S
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1237-1243. PubMed ID: 33211240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension.
    Chowdhury B; Luu AZ; Luu VZ; Kabir MG; Pan Y; Teoh H; Quan A; Sabongui S; Al-Omran M; Bhatt DL; Mazer CD; Connelly KA; Verma S; Hess DA
    Biochem Biophys Res Commun; 2020 Mar; 524(1):50-56. PubMed ID: 31980166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.
    D'Alto M; Badagliacca R; Argiento P; Romeo E; Farro A; Papa S; Sarubbi B; Russo MG; Vizza CD; Golino P; Naeije R
    Chest; 2020 Feb; 157(2):376-383. PubMed ID: 31563498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update.
    Coons JC; Pogue K; Kolodziej AR; Hirsch GA; George MP
    Curr Cardiol Rep; 2019 Nov; 21(11):141. PubMed ID: 31758342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of long-standing pulmonary arterial hypertension and its severity on pulmonary artery aneurysm development.
    Nuche J; Montero-Cabezas JM; Lareo A; Huertas S; Jiménez López-Guarch C; Velázquez Martín M; Alonso Charterina S; Revilla Ostolaza Y; Delgado JF; Arribas Ynsaurriaga F; Escribano Subías P
    Heart Vessels; 2020 Sep; 35(9):1290-1298. PubMed ID: 32248253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connexin43, A Promising Target to Reduce Cardiac Arrhythmia Burden in Pulmonary Arterial Hypertension.
    Sykora M; Szeiffova Bacova B; Andelova K; Egan Benova T; Martiskova A; Kurahara LH; Hirano K; Tribulova N
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical diagnostic value of circulating serum miR-509-3p in pulmonary arterial hypertension with congenital heart disease.
    Tang P
    Hellenic J Cardiol; 2020; 61(1):26-30. PubMed ID: 29890280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and risk factors for pulmonary arterial hypertension associated with primary Sjögren's syndrome: 15 new cases from a single center.
    Zhang N; Zhao Y; Wang H; Sun W; Chen M; Fan Q; Yang Z; Wei W
    Int J Rheum Dis; 2019 Sep; 22(9):1775-1781. PubMed ID: 31368254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway.
    Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S
    Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.
    Saxer S; Lichtblau M; Berlier C; Hasler ED; Schwarz EI; Ulrich S
    Lung; 2019 Oct; 197(5):617-625. PubMed ID: 31263960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.